Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis

Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis

Objectives Anatomical variation of the sacroiliac (SI) joints is common and specific variants are associated with erosions and bone marrow oedema on imaging. Our investigation aims to evaluate whether anatomical variations influence the clinical presentation of axial spondyloarthritis (axSpA).Method...

Full description

Saved in:

Bibliographic Details
Main Authors:	Denis Poddubnyy, Torsten Diekhoff, Sevtap Tugce Ulas, Fabian Proft, Valeria Rios Rodriguez, Judith Rademacher, Juliane Greese, Katharina Ziegeler, Carolina Dominguez Aleixo, Maximilian Lindholz
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-02-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/1/e004923.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis
by: Denis Poddubnyy, et al.
Published: (2024-12-01)

Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
by: Joachim Sieper, et al.
Published: (2025-01-01)

Oxford textbook of axial spondyloarthritis
by: Vinod Ravindran
Published: (2017-01-01)

Antiphospholipid Syndrome Associated with Nonradiographic Axial Spondyloarthritis
by: Jozélio Freire De Carvalho, et al.
Published: (2021-01-01)

Temporal Approach, Digitally Assisted Phacovitrectomy in a Patient with Severe Kyphosis due to Axial Spondyloarthritis
by: J. Rios-Nequis Geovanni, et al.
Published: (2021-01-01)

Sulfasalzine in the management of pure axial spondyloarthritis: Need to have a relook!
by: Subramanian Shankar, et al.
Published: (2020-01-01)

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)

Occurrence and assessment of chronic pain fatigue and sleep disturbance in axial spondyloarthritis patients
by: Eman Abdel Ghani Sayed, et al.
Published: (2025-12-01)

South African Rheumatism and Arthritis Association 2024 guidelines for the management of axial spondyloarthritis
by: A B Maharaj, et al.
Published: (2024-10-01)

The serum level of sclerostin decreases in radiographic axial spondyloarthritis patients with fatty lesions
by: Xuegang Li, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

Efficacy of short term non steroidal anti-inflammatory drugs in Indian patients with axial spondyloarthritis
by: Shubha Bhalla, et al.
Published: (2018-01-01)

Axial Spondyloarthritis in Black Americans: An Observational Study From Five Centers in Shelby County, Tennessee
by: Krishna Kommineni, et al.
Published: (2025-01-01)

Distribution of spinal damage in patients with axial spondyloarthritis as assessed by MRI: a prospective and blinded study
by: Andreas Haidmayer, et al.
Published: (2025-01-01)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
by: Xenofon Baraliakos, et al.
Published: (2020-09-01)

Axial spondyloarthritis in India: determining the delay in diagnosis, impact on work productivity, and attitude of patients toward treatment
by: Kamini Narendra Reddy, et al.
Published: (2020-01-01)

Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01)

Spectrum of spondyloarthritis
by: Himanshu Pathak, et al.
Published: (2020-01-01)

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment
by: Paweł Żuchowski, et al.
Published: (2024-12-01)

Rare Case Studies of Bilateral and Symmetric Sacroiliac Disease
by: Stephen Soloway, et al.
Published: (2024-01-01)

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension
by: Sofia Ramiro, et al.
Published: (2025-01-01)

Comparing the Accuracy and Reliability of Detecting the Intensity of Spinal Inflammation on STIR Sequence with Apparent Diffusion Coefficient Values in Axial Spondyloarthritis
by: Ho Yin Chung, et al.
Published: (2024-12-01)

Accessory sacroiliac joints: A commonly misinterpreted mimic of spondyloarthropathy
by: Shivraj Padiyar, et al.
Published: (2022-01-01)

Serum levels of tumor necrosis factor-alpha and vascular endothelial growth factor as markers of disease activity in patients with axial spondyloarthritis
by: Mahendran Bhuvanesh, et al.
Published: (2018-01-01)

Current concepts in the pathogenesis of spondyloarthritis
by: Nibha Jain, et al.
Published: (2020-01-01)

Contrasting results in sacroiliac joint fusion studies: the role of bilateral complaints
by: Nick Kampkuiper, et al.
Published: (2025-01-01)

Travel-Associated Salmonella mbandaka Sacroiliac Osteomyelitis in a Healthy Adolescent
by: Kirsty Le Doare, et al.
Published: (2013-01-01)

Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients
by: Rick Wilbrink, et al.
Published: (2025-06-01)

Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01)

Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors
by: Maria Iacovantuono, et al.
Published: (2025-02-01)

Enteropathic Spondyloarthritis: From Diagnosis to Treatment
by: Rosario Peluso, et al.
Published: (2013-01-01)

Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
by: Xiaomei Li, et al.
Published: (2025-01-01)

Myeloid-related proteins 8/14 failed to act as theragnostic biomarker in axial spondyloarthritis patients on combination disease-modifying anti-rheumatic drugs therapy
by: Arvind Ganapati, et al.
Published: (2020-01-01)

Analysis of the Importance of Sacroiliac Joint Fractures as a Prognostic Factor of the Patients with Pelvic Fractures
by: Yeon-Uk Ju, et al.
Published: (2018-04-01)

Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
Published: (2025-01-01)

Diagnosis of spondyloarthritis: Application of criteria in clinical practice
by: Sham Santhanam, et al.
Published: (2020-01-01)

Clinical Characteristics and Treatment Options of Peripheral Spondyloarthritis
by: ZENG Lulu, et al.
Published: (2024-12-01)

Anatomy of the sacroiliac joint with relation to the lumbosacral trunk: Is there sufficient space for a two-hole plate?
by: Michał Kułakowski, et al.
Published: (2023-01-01)

Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis
by: Merete Lund Hetland, et al.
Published: (2024-12-01)

IL-7 is a Key Driver Cytokine in Spondyloarthritis?
by: Rafaela Silva Guimarães Gonçalves, et al.
Published: (2019-01-01)